Which medication listed is a GLP-1 receptor agonist used to treat type 2 diabetes mellitus?

Prepare for the Certification in Clinical Sleep Health exam. Use flashcards and multiple-choice questions with hints and explanations. Ace your exam!

Multiple Choice

Which medication listed is a GLP-1 receptor agonist used to treat type 2 diabetes mellitus?

Explanation:
GLP-1 receptor agonists imitate the incretin hormone GLP-1, boosting glucose-dependent insulin secretion, suppressing glucagon when glucose is high, and slowing gastric emptying to help lower blood sugar and often promote weight loss. Byetta is exenatide, a GLP-1 receptor agonist used to treat type 2 diabetes. The other drugs shown belong to different classes: Januvia is a DPP-4 inhibitor that increases endogenous GLP-1 levels by preventing its breakdown, Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity, and Invokana is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys.

GLP-1 receptor agonists imitate the incretin hormone GLP-1, boosting glucose-dependent insulin secretion, suppressing glucagon when glucose is high, and slowing gastric emptying to help lower blood sugar and often promote weight loss. Byetta is exenatide, a GLP-1 receptor agonist used to treat type 2 diabetes. The other drugs shown belong to different classes: Januvia is a DPP-4 inhibitor that increases endogenous GLP-1 levels by preventing its breakdown, Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity, and Invokana is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy